BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 12525621)

  • 1. Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.
    Thomsen DR; Oien NL; Hopkins TA; Knechtel ML; Brideau RJ; Wathen MW; Homa FL
    J Virol; 2003 Feb; 77(3):1868-76. PubMed ID: 12525621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
    Schnute ME; Cudahy MM; Brideau RJ; Homa FL; Hopkins TA; Knechtel ML; Oien NL; Pitts TW; Poorman RA; Wathen MW; Wieber JL
    J Med Chem; 2005 Sep; 48(18):5794-804. PubMed ID: 16134946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
    Piret J; Goyette N; Eckenroth BE; Drouot E; Götte M; Boivin G
    J Virol; 2015 Apr; 89(8):4636-44. PubMed ID: 25673718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesviruses.
    Brideau RJ; Knechtel ML; Huang A; Vaillancourt VA; Vera EE; Oien NL; Hopkins TA; Wieber JL; Wilkinson KF; Rush BD; Schwende FJ; Wathen MW
    Antiviral Res; 2002 Apr; 54(1):19-28. PubMed ID: 11888654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
    Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
    J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutation in the DNA polymerase accessory factor of herpes simplex virus 1 restores viral DNA replication in the presence of raltegravir.
    Zhou B; Yang K; Wills E; Tang L; Baines JD
    J Virol; 2014 Oct; 88(19):11121-9. PubMed ID: 25008933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of methylenecyclopropane analogs of nucleosides against herpesvirus replication in vitro.
    Kushner NL; Williams SL; Hartline CB; Harden EA; Bidanset DJ; Chen X; Zemlicka J; Kern ER
    Nucleosides Nucleotides Nucleic Acids; 2003 Dec; 22(12):2105-19. PubMed ID: 14714760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential impact of various substitutions at codon 715 in region II of HSV-1 and HCMV DNA polymerases.
    Zarrouk K; Zhu X; Goyette N; Piret J; Shi R; Boivin G
    Antiviral Res; 2021 Apr; 188():105046. PubMed ID: 33588012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymerase.
    Topalis D; Gillemot S; Snoeck R; Andrei G
    Nucleic Acids Res; 2016 Nov; 44(20):9530-9554. PubMed ID: 27694307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses.
    Williams SL; Hartline CB; Kushner NL; Harden EA; Bidanset DJ; Drach JC; Townsend LB; Underwood MR; Biron KK; Kern ER
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2186-92. PubMed ID: 12821466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic characterization of the DNA polymerase and sensitivity to antiviral compounds of foscarnet-resistant herpes simplex virus type 1 (HSV-1) derived from a foscarnet-sensitive HSV-1 strain.
    Saijo M; Suzutani T; Morikawa S; Kurane I
    Antimicrob Agents Chemother; 2005 Feb; 49(2):606-11. PubMed ID: 15673740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of DNA polymerase-associated acyclovir-resistant herpes simplex virus type 1: mutations, sensitivity to antiviral compounds, neurovirulence, and in-vivo sensitivity to treatment.
    Wang LX; Takayama-Ito M; Kinoshita-Yamaguchi H; Kakiuchi S; Suzutani T; Nakamichi K; Lim CK; Kurane I; Saijo M
    Jpn J Infect Dis; 2013; 66(5):404-10. PubMed ID: 24047739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-Metal Ion-Dependent Enzymes as Potential Antiviral Targets in Human Herpesviruses.
    DiScipio KA; Weerasooriya S; Szczepaniak R; Hazeen A; Wright LR; Wright DL; Weller SK
    mBio; 2022 Feb; 13(1):e0322621. PubMed ID: 35073739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad-spectrum antiherpes activities of 4-hydroxyquinoline carboxamides, a novel class of herpesvirus polymerase inhibitors.
    Oien NL; Brideau RJ; Hopkins TA; Wieber JL; Knechtel ML; Shelly JA; Anstadt RA; Wells PA; Poorman RA; Huang A; Vaillancourt VA; Clayton TL; Tucker JA; Wathen MW
    Antimicrob Agents Chemother; 2002 Mar; 46(3):724-30. PubMed ID: 11850254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of nucleotidyltransferase superfamily enzymes suppress herpes simplex virus replication.
    Tavis JE; Wang H; Tollefson AE; Ying B; Korom M; Cheng X; Cao F; Davis KL; Wold WS; Morrison LA
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7451-61. PubMed ID: 25267681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenoxazine derivatives inactivate human cytomegalovirus, herpes simplex virus-1, and herpes simplex virus-2 in vitro.
    Hayashi K; Hayashi T; Tomoda A
    J Pharmacol Sci; 2008 Mar; 106(3):369-75. PubMed ID: 18319567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
    Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
    Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of virus strains resistant to the herpes virus helicase-primase inhibitor ASP2151 (Amenamevir).
    Chono K; Katsumata K; Kontani T; Shiraki K; Suzuki H
    Biochem Pharmacol; 2012 Aug; 84(4):459-67. PubMed ID: 22687623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridines as broad-spectrum inhibitors of human herpesvirus polymerases.
    Schnute ME; Anderson DJ; Brideau RJ; Ciske FL; Collier SA; Cudahy MM; Eggen M; Genin MJ; Hopkins TA; Judge TM; Kim EJ; Knechtel ML; Nair SK; Nieman JA; Oien NL; Scott A; Tanis SP; Vaillancourt VA; Wathen MW; Wieber JL
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3349-53. PubMed ID: 17434304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The UL97 protein kinase of human cytomegalovirus and homologues in other herpesviruses: impact on virus and host.
    Michel D; Mertens T
    Biochim Biophys Acta; 2004 Mar; 1697(1-2):169-80. PubMed ID: 15023359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.